Found 7 matching trials
A Study of BGM0504 in Participants with Type 2 Diabetes
PHASE3This trial is conducted in China. The aim of the trial is to evaluate the e...
Location
Peking University People's Hospital
A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
PHASE1The study will look at how two different forms of semaglutide reach and sta...
Location
Novo Nordisk Investigational Site
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
PHASE2Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by prog...
Location
Ministry of Health Medical City
A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
PHASE1The study will look at how 2 different semaglutide versions reach and stay ...
Location
Novo Nordisk Investigational Site
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
PHASE2Adult participants with BMI between 22 - 35 kg/m2 will be enrolled and rand...
A Study of BGM0504 in Chinese Patients With Type 2 Diabetes
PHASE2The purpose of this study is to evaluate the efficacy and safety of BGM0504...
Location
The Third Xiangya Hospital of Central South University
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
PHASE3The reason for this study is to compare the effect of the study drug RAY122...
Location
Peking University People's Hospital